The FDA label for semaglutide (Wegovy) reports that 11 percent of trial participants experienced fatigue, a little bit more than twice as often as those who used a placebo
At full therapeutic doses, roughly 40% of patients experience GI side effects severe enough to consider stopping
Step two: request bloodwork including a comprehensive metabolic panel and magnesium level
Eating smaller, more frequent meals rather than large portions can reduce the burden on the digestive system
These medications can be incredibly helpful, but theyre not risk-free, especially during pregnancy. The study found that 2.2% of women became pregnant within six months of starting GLP-1 treatment with pregnancy rates highest among younger women with diabetes, and among women without diabetes in their early thirties
I'm far more interested in: Lowering inflammation Protecting my cardiovascular health